ANHUI HUANGSHAN CAPSULE (002817.SZ)

Friday

9:20 PM

Thesis: Recent revenue declines and potential regulatory challenges are raising concerns among investors about the company's near-term growth prospects.

Revenue Outlook

Metric	FY2024	FY2025
Revenue	$473M	$458M
Rev. Growth	+2.3%	-3.3%
EPS	$0.16	$0.22
EPS Growth	-27.3%	+37.5%
P/E	41.0×	29.8×

What Moves the Stock

1Changes in regulatory standards affecting capsule manufacturing
2Demand fluctuations in the pharmaceutical sector, particularly in China
3Raw material price volatility impacting production costs
4Technological advancements in capsule production methods
5Pharmaceutical capsules - 80%
6Nutraceutical capsules - 15%
7Other products - 5%
8Health and wellness trends driving demand for nutraceutical products

FY2025 Snapshot

Revenue: $458M
Rev. Growth: -3.3%
Gross Margin: 27.7%
Op. Margin: 12.4%
Net Margin: 14.2%
Net Income: $65M
NI Growth: +31.9%
EPS: $0.22
1Y Return: -16.2%

002817.SZ Chart

My Notes

"Management noted, 'While we are seeing strong demand in certain segments, regulatory pressures could impact our margins moving forward.'"
Moat: The company's established reputation for quality and compliance provides a moderate moat, though it faces increasing competition.
value - Investors may be drawn to the company's low debt levels and stable cash flows despite recent revenue declines.
Interest rates have minimal direct impact on the company's operations due to low debt levels…
Watch on earnings: Raw material price indices (e.g., gelatin prices), Pharmaceutical industry growth rates in China, Regulatory changes impacting manufacturing standards.

One Sentence Summary:

Anhui Huangshan Capsule: the story is balanced — changes in regulatory standards affecting capsule manufacturing.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance